Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Image sensor with improved color crosstalk
System and method for customized prompting
Nanowire structured photodiode with a surrounding epitaxially grown P or N layer
Methods and systems for adapting a user environment
Method, apparatus, and system for energy efficiency and energy conservation including dynamic cache sizing and cache operating voltage management for optimal power performance
Device and implantation system for electrical stimulation of biological systems
Electronic device and printed circuit board
  Randomly Featured Patents
Circulating a liquid through a joint
Flexible package with easy opening peel seal
Formable composite laminates with cellulose-containing polymer resin sheets
Cash dispensing automated banking machine diagnostic device
Surface treatment for silicon carbide filaments and product
Scroll compressor with shaft seal lubrication
Release agent applicator for imaging members in solid ink jet imaging systems
Inhibitors of hydroxyphenylpyruvate dioxygenase and an assay for identification of inhibitors
Mastectomy garments with built-in prosthetic device
Method for manufacturing a semiconductor device